Type II cryoglobulinemia is not associated with hepatitis C infection: The Dutch experience

Annals of the New York Academy of Sciences

Volumn 1107, Issue , 2007, Pages 251-258

  Cohen Tervaert, Jan Willem ^a   Van Paassen, P ^a   Damoiseaux, J ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cryoprecipitate; Glomerulonephritis; Hepatitis C; Mixed cryoglobulinemia; Non alcoholic steatohepatis

Indexed keywords

HEPATITIS C ANTIBODY; HEPATITIS ANTIBODY;

ADULT; AGED; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; CONFERENCE PAPER; CRYOGLOBULINEMIA; FEMALE; FOLLOW UP; HEPATITIS C; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOPROLIFERATIVE DISEASE; MALE; PATIENT REFERRAL; POLYMERASE CHAIN REACTION; ARTICLE; BIOPSY; CASE REPORT; CLASSIFICATION; CROSS-SECTIONAL STUDY; IMMUNOLOGY; LYMPHOMA; MIDDLE AGED; NETHERLANDS; PATHOLOGY; VIROLOGY;

HEPATITIS C VIRUS;

ADULT; AGED; BIOPSY; CROSS-SECTIONAL STUDIES; CRYOGLOBULINEMIA; HEPATITIS ANTIBODIES; HEPATITIS C; HUMANS; LYMPHOMA; MALE; MIDDLE AGED; NETHERLANDS;

EID: 34648817584     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1381.027     Document Type: Conference Paper

References (21)

1. MISIANI, R., P. BELLAVITA, D. FENILI, et al. 1992. Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Ann. Intern. Med. 117: 573-577.
2. AGNELLO, V., R.T. CHUNG & L.M. KAPLAN. 1992. A role for hepatitis C virus infection in type II cryoglobulinemia. N. Engl. J. Med. 327: 1490-1495.
3. CACOUB, P., F.L. FABIANI, L. MUSSET, et al. 1994. Mixed cryoglobulinemia and hepatitis C virus. Am. J. Med. 96: 124-132.
4. FERRI, C., M. SEBASTIANI, D. GIUGGIOLI, et al. 2004. Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients. Semin. Arthritis Rheum. 33: 355-374.
5. CATALANI, C., A. BIGGERI, A. GOTTARD, et al. 2004. Prevalence of HCV infection among health care workers in a hospital in central Italy. Eur. J. Epidemiol. 19: 73-77.
6. ANSALDI, F., B. BRUZZONE, S. SALMASO, et al. 2005. Different seroprevalence and molecular epidemiology patterns of hepatitis C virus infection in Italy. J. Med. Virol. 76: 327-332.
7. CECERE, A., F. MAROTTA, A. LUCARIELLO, et al. 2003. High prevalence of hepatitis C virus infection in a southern Italian rural region. Clinical aspects and evidence of inapparent parenteral exposure. Panminerva Med. 45: 253-259.
8. BRONOWICKI, J.P., H. BARRAUD & L. PEYRIN-BIROULET. 2005. Epidemiology and natural history of hepatitis C. Rev. Prat. 55: 607-614.
9. SAADOUN, D., J. SELLAM, P. GHILLANI-DALBIN, et al. 2006. Increased risks of lymphoma and death among patients with non-hepatitis C virus-related mixed cryoglobulinemia. Arch. Intern. Med. 166: 2101-2108.
10. OP DE COUL, E., A. BOSMAN & M. LAAR VAN DE. 2003. Surveillance of hepatitis C infection in the Netherlands, 1992-2002. Inf. Bull. 14: 323-328.
11. VITALI, C., S. BOMBARDIERI, R. JONSSON, et al. 2002. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European consensus group. Ann. Rheum. Dis. 61: 554-558.
12. HOCHBERG, M.C. 1997. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 40: 1725.
13. ARNETT, F.C., S.M. EDWORTHY, D.A. BLOCH, et al. 1998. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31: 315-324.
14. MASI, A.T. 1980. Subcommittee for scleroderma criteria of the American Rheumatism Association diagnostic and therapeutic criteria committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum. 23: 581-590.
15. MIYAKIS, S., M. LOCKSHIN, T. ATSUMI, et al. 2006. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J. Thromb. Haemost. 4: 295-306.
16. ALARÇON-SEGOVIA, D. & M.H. CARDIEL. 1989. Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients. J. Rheumatol. 16: 328-334.
17. HARRIS, N.L., E.S. JAFFE, J. DIEBOLD, et al. 1999. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the clinical advisory committee meeting - Airlie House, Virginia, 1997. Clin. Oncol. 17: 3835-3849.
18. BROUET, J.C., J.P. CLAUVEL, F. DANON, et al. 1974. Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am. J. Med. 57: 775-788.
19. KLEIN, F.& M.B. JANSSENS. 1987. Standardisation of serological tests for rheumatoid factor measurement. Ann. Rheum. Dis. 46: 674-680.
20. SEELEN, M.A., A. ROOS, J. WIESLANDER, et al. 2005. Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA. J. Immunol Methods 296: 187-198.
21. KAY, J. & R.T. MCCLUSKEY. 2005. Case 31-2005: a 60-year-old man with skin lesions and renal insufficiency. N. Engl. J. Med. 353: 1605-1613.